| ASSET | QUARTER | % RETURN |
|---|---|---|
Nixxy (NIXX) | Q3 2017 | 952.63% |
PetVivo (PETV) | Q3 2017 | 475.07% |
Veritone (VERI) | Q3 2017 | 279.38% |
IZEA (IZEA) | Q3 2017 | 273.68% |
Nutex Health (NUTX) | Q3 2017 | 266.67% |
Capricor Therapeutics (CAPR) | Q3 2017 | 265.06% |
CareDx (CDNA) | Q3 2017 | 224.56% |
Zynex (ZYXI) | Q3 2017 | 208.24% |
Quantum Computing (QUBT) | Q3 2017 | 200% |
XOMA (XOMA) | Q3 2017 | 181.92% |
Madrigal Pharmaceuticals (MDGL) | Q3 2017 | 177.14% |
Almonty Industries Inc Common Shares (ALM) | Q3 2017 | 172.21% |
Abeona Therapeutics (ABEO) | Q3 2017 | 168.5% |
Arrowhead Pharmaceuticals (ARWR) | Q3 2017 | 164.02% |
Cibus Global LLC (CBUS) | Q3 2017 | 157.79% |
HIVE Blockchain Technologies (HIVE) | Q3 2017 | 156.29% |
Veru (VERU) | Q3 2017 | 150% |
Ascent Solar Technologies, Inc Common Stock (ASTI) | Q3 2017 | 150% |
TDH (PETZ) | Q3 2017 | 148.89% |
Processa Pharmaceuticals (PCSA) | Q3 2017 | 140% |
BioLife Solutions (BLFS) | Q3 2017 | 137.92% |
Empire Petroleum (EP) | Q3 2017 | 137.5% |
Voyager Therapeutics (VYGR) | Q3 2017 | 133.71% |
BeiGene (ONC) | Q3 2017 | 128.84% |
Dynavax Technologies (DVAX) | Q3 2017 | 123.96% |
